Please assess the completion status of the following clinical trial:

Trial Title: Optical Head-Mounted Display Technology for Low Vision Rehabilitation

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria for subjects with retinal dystrophy:~* diagnosis of retinal dystrophy~* severe vision loss that constitutes legal blindness~* able to perform a reliable Goldmann visual field test~* constricted visual field less than or equal to 20 degrees by Goldmann perimetry using the III4e stimulus in at least one eye with best-corrected visual acuity ≥ 20/60~Inclusion criteria for control subjects:~* healthy controls~* visit history with the Comprehensive and Pediatric Ophthalmology Services at the University of Michigan~* able to perform a reliable Goldmann visual field test~Exclusion criteria for subjects with retinal dystrophy:~* movement disorder that precludes evaluation of mobility~* functional vision loss~* pregnant women~Exclusion criteria for control subjects:~* visually significant ocular condition other than correctable refractive error~* movement disorder that precludes evaluation of mobility~* functional vision loss~* pregnant women

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Retinal Dystrophy (Type: EXPERIMENTAL): Subjects with retinal dystrophy will have their visual field, gait and self-reported mobility tested at baseline. Subjects will then be fit with a head-mounted display and undergo a brief training with the investigators to learn about use of the device. After a 2 week period of in-home adaptation to the device, their visual field, gait and self-reported mobility will be retested.
- Healthy Age-Matched Controls (Type: EXPERIMENTAL): Age-matched control subjects without eye disease will have their visual field, gait and self-reported mobility tested at baseline. Control subjects will then be fit with a head-mounted display and undergo a brief training with the investigators to learn about use of the device. After a 2 week period of in-home adaptation to the device, their visual field, gait and self-reported mobility will be retested.

Based on this trial design, predict the completion outcome and termination type (if applicable).